Details for Patent: 10,543,192
Which drugs does patent 10,543,192 protect, and when does it expire?
Patent 10,543,192 protects QBREXZA and is included in one NDA.
This patent has twenty-nine patent family members in thirteen countries.
Summary for Patent: 10,543,192
| Title: | Glycopyrrolate salts |
| Abstract: | Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed. |
| Inventor(s): | John Allan STATLER, Anthony Adrian SHAW, Delphine Caroline Imbert, Jennifer Leigh NELSON, Patricia Andres, Lisa Lynn McQueen, Stephan Xander Mattheus BOERRIGTER, Jon Gordon Selbo, Mark Christopher Andres |
| Assignee: | Journey Medical Corp |
| Application Number: | US15/996,353 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,543,192 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 10,543,192
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | QBREXZA | glycopyrronium tosylate | CLOTH;TOPICAL | 210361-001 | Jun 28, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,543,192
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014223172 | ⤷ Start Trial | |||
| Australia | 2016269524 | ⤷ Start Trial | |||
| Canada | 2902795 | ⤷ Start Trial | |||
| China | 105026369 | ⤷ Start Trial | |||
| European Patent Office | 2961734 | ⤷ Start Trial | |||
| European Patent Office | 3473615 | ⤷ Start Trial | |||
| European Patent Office | 3842419 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
